Poor ovarian response population of ART are considered the biggest challenge for providers. Hitherto, no one protocol has been proven to be effect in this subgroup of IVF patients. Metoclopramide belongs to the antiemetic group, used for motion sickness and during early gestation for hyperemesis gravidarum. The mechanism of action is antagonisim to dopamine receptors. We hypothesize than by blocking dopamine receptors and decreasing the dopaminergic tone there is a possibility to increase the sensitivity of ovarian response to gonadotropins during controlled ovarian stimulation and result in increased oocyte retrival.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
60
Metoclopramide 10 mg BID
Placebo 10 mg BID
Barzilai University Medical Center
Ashkelon, Ashkelon District, Israel
RECRUITINGNumber of oocytes
Number of oocytes
Time frame: Approximately 5 weeks from first dose of study drug
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.